Distinction of melanoma in situ from solar lentigo on sun-damaged skin using morphometrics and MITF immunohistochemistry

American Journal of Dermatopathology

Volumn 33, Issue 6, 2011, Pages 573-578

  Black, Will H ^a   Thareja, Sumeet K ^a   Blake, Brett P ^e   Chen, Ren ^d   Cherpelis, Basil S ^a,b   Glass, Lewis Frank ^a,b,c  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

chronically sun damaged skin; melanoma in situ; MITF immunohistochemistry; morphometrics; solar lentigo

Indexed keywords

EOSIN; HEMATOXYLIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURGERY; CARCINOMA IN SITU; CELL DENSITY; CELL LABELING; CELL NUCLEUS; CELL SIZE; CHEMOSURGERY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LENTIGO; MALE; MELANOCYTE; MELANOMA; MELANOMA IN SITU; MORPHOMETRICS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SKIN INJURY; SOLAR LENTIGO; SUN DAMAGED SKIN;

AGED; AGED, 80 AND OVER; CELL NUCLEUS; DERMATITIS, PHOTOTOXIC; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MIDDLE AGED; SKIN NEOPLASMS; SUNBURN; SUNLIGHT; TUMOR MARKERS, BIOLOGICAL;

EID: 79961210512     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3182093b13     Document Type: Article

References (38)

1. Mitchell RE. The effect of prolonged solar radiation on melanocytes of the human epidermis. J Invest Dermatol. 1963;41:199-212.
2. Rosdahl I. The epidermal melanocyte population and its reaction to ultraviolet light. Acta Derm Venereol Suppl. 1979;88:1-43.
3. Gilcrest BA, Blog FB, Szabo G. Effects of aging and chronic sun exposure on melanocytes in human skin. J Invest Dermatol. 1979;73:141-143. (Pubitemid 10142211)
4. Rhodes AR, Harrist TJ, Momtaz TK. The PUVA-induced pigmented macule: a lentiginous proliferation of large, sometimes cytologically atypical, melanocytes. J Am Acad Dermatol. 1983;9:47-58. (Pubitemid 13068676)
5. Weyers W, Bonczkowitz M, Weyers I, et al. Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis. Am J Dermatopathol. 1996;18:560-566. (Pubitemid 27020167)
6. Acker SM, Nicholson JH, Rust PF, et al. Morphometric discrimination of melanoma in situ of sun-damaged skin from chronically sun-damaged skin. J Am Acad Dermatol. 1998;39:239-245. (Pubitemid 28367336)
7. Barlow JO, Maize J, Lang PG. The density and distribution of melanocytes adjacent to melanoma and nonmelanoma skin cancers. Dermatol Surg. 2007;33:199-207. (Pubitemid 46208113)
8. Hendi A, Brodland DG, Zitelli JA. Melanocytes in long-standing sun-exposed skin: quantitative analysis using the MART-1 immunostain. Arch Dermatol. 2006;142:871-876. (Pubitemid 44079787)
9. Albertini JG, Elston DM, Libow LF, et al. Mohs micrographic surgery for melanoma: a case series, a comparative study of immunostains, an informative case report, and a unique mapping technique. Dermatol Surg. 2002;28:656-665. (Pubitemid 34913271)
10. Zalla MJ, Lim KK, Dicaudo DJ, et al. Mohs micrographic excision of melanoma using immunostains. Dermatol Surg. 2000;26:771-784. (Pubitemid 30620524)
11. Kelley LC, Starkus L. Immunohistochemical staining of lentigo maligna during Mohs micrographic surgery using MART-1. J Am Acad Dermatol. 2002;46:78-84. (Pubitemid 34073482)
12. Stranahan D, Cherpelis BS, Glass LF, et al. Immunohistochemical stains in Mohs surgery: a review. Dermatol Surg. 2009;35:1023-1034.
13. Thosani MK, Marghoob A, Chen CS. Current progress of immunostains in Mohs micrographic surgery: a review. Dermatol Surg. 2008;34: 1621-1636.
14. Dawn ME, Dawn AG, Miller SJ. Mohs surgery for the treatment of melanoma in situ: a review. Dermatol Surg. 2007;33:395-402. (Pubitemid 46570109)
15. Davis DA, Kurtz KA, Robinson RA. Ultrarapid staining for cutaneous melanoma: study and protocol. Dermatol Surg. 2005;31:753-756. (Pubitemid 43110101)
16. Beltraminelli H, Shabrawi-Caelen LE, Kerl H, et al. Melan-a-positive "pseudomelanocytic nests": a pitfall in the histopathologic and immunohistochemical diagnosis of pigmented lesions on sun-damaged skin. Am J Dermatopathol. 2009;31:305-308.
17. Maize JC Jr, Resneck JS Jr, Shapiro PE, et al. Ducking stray "magic bullets": a Melan-A alert. Am J Dermatopathol. 2003;25:162-165. (Pubitemid 36350464)
18. Miettinen M, Fernandez M, Franssila K, et al. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers. Am J Surg Pathol. 2001;25:205-211. (Pubitemid 32167502)
19. Granter SR, Weilbaecher KN, Quigley C, et al. Role for microphthalmia transcription factor in the diagnosis of metastatic malignant melanoma. Appl Immunohistochem Mol Morphol. 2002;10:47-51. (Pubitemid 34178276)
20. King R, Googe PB, Weilbaecher KN, et al. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol. 2001;25:51-57. (Pubitemid 32001832)
21. King R, Weilbaecher KN, McGill G, et al. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for melanoma diagnosis. Am J Pathol. 1999;155:731-738. (Pubitemid 29426819)
22. Busam KJ, Iversen K, Coplan KC, et al. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol. 2001;25: 197-204. (Pubitemid 32167501)
23. Busam KJ, Kucukgöl D, Sato E, et al. Immunohistochemical analysis of novel monoclonal antibody PNL2 and comparison with other melanocyte differentiation markers. Am J Surg Pathol. 2005;29:400-406. (Pubitemid 40321977)
24. Bertolotto C, Abbe P, Hemesath TJ, et al. Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes. J Cell Biol. 1998;142:827-835. (Pubitemid 28381498)
25. Barnhill RL, Piepkorn M, Busam KJ. Pathology of Melanocytic Nevi and Malignant Melanoma. New York, NY. Springer Science+Business Media, Inc; 2004.
26. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology. Melanoma [Internet]. 2007. Available at: http://www.nccn.org/ professionals/physician-gls/PDF/melanoma.pdf. Accessed August 1, 2010.
27. National Institutes of Health Consensus Development Conference Statement on Diagnosis and Treatment of Early Melanoma, January 27-29, 1992. Am J Dermatopathol. 1993;15:34-43; discussion 46-51.
28. Bricca GM, Brodland DG, Ren D, et al. Cutaneous head and neck melanoma treated with Mohs micrographic surgery. J Am Acad Dermatol. 2005;52:92-100. (Pubitemid 40038940)
29. Huilgol SC, Selva D, Chen C, et al. Surgical margins for lentigo maligna and lentigo maligna melanoma: the technique of mapped serial excision. Arch Dermatol. 2004;140:1087-1092. (Pubitemid 39223116)
30. Agarwal-Antal N, Bowen GM, Gerwels JW. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J Am Acad Dermatol. 2002;47:743-748. (Pubitemid 35239337)
31. Moller MG, Pappas-Politis E, Zager JS, et al. Surgical management of melanoma-in-situ using a staged marginal and central excision technique. Ann Surg Oncol. 2009;16:1526-1536.
32. Bub JL, Berg D, Slee A, et al. Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up. Arch Dermatol. 2004;140:552-558. (Pubitemid 38668962)
33. El Shabrawi-Caelen L, Kerl H, Cerroni L. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis. Am J Dermatopathol. 2004;26:364-366. (Pubitemid 39287355)
34. Glass LF, Raziano RM, Clark GS, et al. Rapid frozen section immunostaining of melanocytes by microphthalmia-associated transcription factor. Am J Dermatopathol. 2010;32:319-325.
35. Rhodes AR, Melski JW, Sober AJ, et al. Increased intraepidermal melanocyte frequency and size in dysplastic melanocytic nevi and cutaneous melanoma. A Comparative quantitative study of dysplastic melanocytic nevi, superficial spreading melanoma, nevocellular nevi, and solar lentigines. J Investig Dermatol. 1983;80:452-459. (Pubitemid 13134131)
36. Andersen WK, Labadie RR, Bhawan J. Histopathology of solar lentigines of the face: a quantitative study. J Am Acad Dermatol. 1997;36:444-447. (Pubitemid 27131970)
37. Helm K, Findeis-Hosey J. Immunohistochemistry of pigmented actinic keratoses, actinic keratoses, melanomas in situ and solar lentigines with Melan-A. J Cutan Pathol. 2008;35:931-934.
38. Weedon D. Lentigines, nevi, and melanomas. In: Skin Pathology. Philadelphia, PA: Elsevier's Limited; 2002:713.